INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma
Clinical trial NCT03502785 · COMPLETED
Trial details
- NCT number
- NCT03502785
- Sponsor
- Inovio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2025-05-09
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.